Year-over-year earnings per share growth for the last twelve months: solesence.com (SLSN)

Solesence Inc - graphic logo of issuer SLSN

Solesence Inc is implementing eco-friendly component synthesis that protects the oceans. The brand is valued for creating medical-grade mineral filters for premium cosmetics. The automation of workshops via robotics is reducing personnel costs. Tracking quarterly EPS growth helps assess revenue dynamics, while 457.00 represents the latest metric reading.

Solesence (SLSN) Year-over-year net earnings per share change for the last twelve months: for the period 04/09/2025 - 11/15/2026

Financial and market metric breakdowns for solesence.com (SLSN)

- share price and expert price forecast:
Stock Price Solesence Inc|SLSN - Analyst Median Target
- company stock exchange capitalization indicators:
Market Value Solesence Beauty|SLSN - Business Value
- book capitalization data:
Net Assets per Single Share Solesence Inc|SLSN - Book Valuation of Business|Market Value to Book Value Ratio solesence.com|SLSN - Company Assets
- debt and solvency information:
Debt to Equity Solesence Inc|SLSN - Long-Term Debt to Equity|Short-Term Debt to Capital solesence.com|SLSN - Company Cumulative Debt|Debt to Book Capitalization Ratio Solesence Beauty|SLSN - Long-Term Debt Volume|Company Short-Term Debts Solesence Inc|Quick Liquidity solesence.com
- earnings and market multiples details:
SLSN - Company Profit|Projected Future Earnings Solesence Inc|SLSN - Price to Earnings Ratio|Forward P/E Multiple solesence.com|SLSN - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Solesence|SLSN - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Solesence Inc|SLSN - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months solesence.com|SLSN - Earnings per share growth this year|Earnings growth forecast for next year Solesence Inc
- sales and revenue data:
SLSN - Company Sales|Company Projected Revenue Solesence Inc|SLSN - Price-to-Revenue Coefficient|Price-to-Projected Revenue Ratio Solesence Inc|SLSN - Sales Growth YoY (Last Twelve Months)
Comprehensive company analysis:Solesence Inc
Manufactured product of Solesence Inc

Quarterly EPS growth measures the dynamics of net profit per share, reflecting the actual efficiency of value generation for shareholders. This metric allows investors to verify the stability of operating flows and identify undervalued assets. The current quarterly EPS trend, with a value of 457.00, serves as an indicator of the issuer's financial stability. Growth in this figure confirms the capitalization of Solesence Inc. (SLSN) advantages in the field of specialized component transportation. Reliable pharmaceutical-grade logistics minimize the risks of raw material spoilage, ensuring predictable profits.

Competitors of Solesence Inc (SLSN)

KRYS: Quarterly EPS earnings growth|APGE - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Arcutis Biotherapeutics, Inc.|Year-over-year earnings per share growth for the last 12 months VCEL (Vericel)|Year-over-year earnings per share growth for the last twelve months Oruka Pharma (ORKA)|Year-over-year net earnings per share change for the last twelve months Sanara MedTech|Quarterly EPS earnings growth DBVT (DBV Technologies SA)|journeymedicalcorp.com (DERM) - Earnings per share growth in annualized terms for the last twelve months|FBRX - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months EMPG|SLGL (sol-gel.com) - Year-over-year net earnings per share growth for the last 12 months|AXIL (AXIL Brands, Inc.) - Year-over-year earnings per share growth for the last twelve months|MDCX (Medicus Pharma Corp) - Quarterly EPS earnings growth|Verrica Pharmaceuticals (VRCA) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months HOTH (Hoth Therapeutics, Inc.)|BFRI - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth VYNE (VYNE Therapeutics)|Year-over-year earnings per one share growth for the last 12 months SNOA|Quoin Pharmaceuticals Ltd. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Azitra Corporation AZTR|DRMA (Dermata) - Year-over-year net earnings per share growth for the last 12 months|Elevai Labs Inc. (ELAB) - Quarterly EPS earnings growth|RVNC (Revance Therapeutics, Inc.) - Quarterly EPS earnings growth